← Back to guidelines
Thoracic Surgery6 papers

Ostium secundum type atrial septal defect

Last edited: 2 h ago

Overview

Ostium secundum atrial septal defects (ASD) are a common form of congenital heart disease characterized by a hole in the septum between the right and left atria. These defects allow for abnormal shunting of blood between the atria, potentially leading to symptoms such as dyspnea, fatigue, and palpitations, especially with exertion. While many patients remain asymptomatic, untreated ASDs can contribute to long-term complications like atrial fibrillation, pulmonary hypertension, and right heart failure. Given their prevalence (6 to 10 per 10,000 live births) 1, early identification and appropriate management are crucial in clinical practice to prevent these complications and improve quality of life.

Pathophysiology

The pathophysiology of ostium secundum ASDs arises from developmental anomalies during embryogenesis, typically resulting from incomplete fusion of the septum primum and septum secundum. This defect creates a direct communication between the atria, leading to a left-to-right shunt due to the higher pressure in the left atrium compared to the right atrium. Over time, this shunting can lead to volume overload in the pulmonary circulation, causing pulmonary vasodilation and potentially pulmonary hypertension. The hemodynamic consequences include increased pulmonary blood flow, which may manifest clinically as elevated pulmonary artery pressures and right ventricular dilation. Additionally, chronic volume overload can affect cardiac function, predisposing patients to arrhythmias such as atrial fibrillation and, in severe cases, right heart failure 1.

Epidemiology

Ostium secundum ASDs have a relatively consistent incidence, affecting approximately 6 to 10 per 10,000 live births globally 1. The condition is more frequently diagnosed in females compared to males, although the gender disparity is not extreme. Epidemiological studies indicate that the majority of cases are identified in childhood, but some patients may remain asymptomatic until adulthood, with diagnoses often prompted by incidental findings or the onset of symptoms related to increased pulmonary blood flow. Over time, there has been a noted shift towards earlier and more frequent use of transcatheter closure techniques, reflecting advancements in minimally invasive interventions and their favorable outcomes compared to traditional surgical approaches 4.

Clinical Presentation

Patients with ostium secundum ASDs can present with a spectrum of symptoms ranging from asymptomatic to symptomatic. Typical symptoms include dyspnea on exertion, fatigue, and palpitations, often exacerbated by physical activity. Atypical presentations might include recurrent respiratory infections, exercise intolerance, and in severe cases, signs of right heart failure such as peripheral edema and ascites. Red-flag features include syncope, unexplained cyanosis, and signs of severe pulmonary hypertension, which necessitate urgent evaluation and intervention 1.

Diagnosis

The diagnostic approach for ostium secundum ASDs typically begins with clinical suspicion based on symptoms and physical examination findings. Key diagnostic tools include:

  • Echocardiography: Essential for initial diagnosis, providing detailed images of the defect size and shunt direction. Transthoracic echocardiography (TTE) is often sufficient, but transesophageal echocardiography (TEE) may offer more precise anatomical details.
  • Cardiac Catheterization: Used for definitive measurement of shunt volume and hemodynamic assessment, particularly useful when planning interventional closure.
  • Electrocardiography (ECG): May reveal characteristic patterns such as right bundle branch block (RBBB) and isolated negative T waves, which correlate with the magnitude of the shunt (Qp/Qs ratio > 1.5 typically indicates significant shunting) 5.
  • Specific Criteria and Tests:

  • Echocardiographic Findings: Defect size, shunt direction (left-to-right), and presence of other cardiac anomalies.
  • Qp/Qs Ratio: > 1.5 often indicates significant shunting, warranting intervention.
  • Electrocardiographic Signs: Right bundle branch block (RBBB) and isolated negative T waves may correlate with shunt volume 5.
  • Differential Diagnosis

    Conditions that may mimic ostium secundum ASDs include:

  • Ventricular Septal Defect (VSD): Distinguished by the location of the shunt (ventricular rather than atrial) and specific echocardiographic findings.
  • Patent Foramen Ovale (PFO): Smaller defects, often transient, and typically associated with specific clinical scenarios like paradoxical embolism.
  • Mitral Valve Prolapse: Can present with palpitations and dyspnea but lacks the characteristic shunt seen in ASDs.
  • Management

    Transcatheter Device Closure

    First-Line Approach:
  • Device Selection: Amplatzer Septal Occluder (ASO) or Gore Cardioform device.
  • Indications: Isolated ostium secundum ASD, defect size suitable for device closure (typically <30 mm in diameter), absence of significant pulmonary hypertension.
  • Procedure: Performed under general anesthesia, guided by echocardiography.
  • Monitoring: Post-procedural echocardiogram to confirm closure and assess for complications.
  • Contraindications: Severe pulmonary hypertension, multiple defects, or anatomical constraints unsuitable for device placement.
  • Specifics:

  • Device Type: ASO (St. Jude Medical) or Gore Cardioform (W.L. Gore and Associates).
  • Follow-Up: Immediate post-procedure echocardiogram, repeat echocardiogram at 24-48 hours, and routine follow-up at 6 months, 1 year, and annually thereafter.
  • Operative Closure

    Second-Line Approach:
  • Indications: Inability to perform transcatheter closure due to anatomical constraints, large defects, or coexisting cardiac anomalies requiring surgical intervention.
  • Procedure: Open-heart surgery via median sternotomy, direct suture or patch closure.
  • Monitoring: Postoperative echocardiography, clinical assessment for complications like arrhythmias or residual shunt.
  • Specifics:

  • Surgical Techniques: Direct suture repair or patch closure.
  • Postoperative Care: Intensive monitoring in ICU, echocardiography to confirm closure, and gradual mobilization.
  • Refractory Cases

  • Referral to Specialist: Cardiothoracic surgeons or interventional cardiologists for complex anatomical scenarios or recurrent defects.
  • Considerations: Advanced imaging techniques (MRI, CT) for detailed anatomical assessment before planning further interventions.
  • Complications

    Acute Complications:
  • Device Embolization: Rare but serious, requiring immediate intervention.
  • Arrhythmias: Post-procedural atrial arrhythmias, necessitating monitoring and potential antiarrhythmic therapy.
  • Pulmonary Edema: Transient, often managed with diuretics and supportive care.
  • Long-Term Complications:

  • Device-Related Issues: Occasional device erosion or residual shunt requiring reintervention.
  • Pulmonary Hypertension: Progression in untreated cases, highlighting the importance of timely closure.
  • Atrial Fibrillation: Increased risk with chronic volume overload, warranting regular rhythm monitoring.
  • Prognosis & Follow-Up

    The prognosis for patients with successfully closed ostium secundum ASDs is generally favorable, with reduced risk of long-term complications such as pulmonary hypertension and right heart failure. Key prognostic indicators include the absence of significant pulmonary hypertension pre-closure and successful device or surgical closure without residual shunt. Recommended follow-up intervals include:

  • Immediate Post-Procedure: Echocardiography within 24-48 hours.
  • Short-Term: Clinical assessment and repeat echocardiography at 6 months.
  • Long-Term: Annual echocardiograms and clinical evaluations to monitor for any late complications or recurrence.
  • Special Populations

    Pediatrics

  • Considerations: Smaller defect sizes, need for careful device selection (e.g., ASO vs. Gore Cardioform).
  • Management: Emphasis on minimally invasive transcatheter approaches due to lower morbidity.
  • Adults

  • Challenges: Higher likelihood of coexisting cardiovascular disease, requiring thorough pre-procedural evaluation.
  • Approach: Similar to pediatrics but with additional focus on comorbidities and potential need for surgical intervention if transcatheter closure is not feasible.
  • Pregnancy

  • Management: Close monitoring for hemodynamic changes; transcatheter closure is generally preferred if indicated before conception.
  • Postpartum: Reassessment of cardiac status and device function, considering potential physiological changes.
  • Key Recommendations

  • Transcatheter Closure as First-Line: Prefer transcatheter closure for isolated ostium secundum ASDs with suitable defect size and anatomy (Evidence: Strong 13).
  • Echocardiographic Confirmation: Use echocardiography for definitive diagnosis and sizing of the defect (Evidence: Strong 1).
  • Qp/Qs Ratio Monitoring: Consider Qp/Qs ratio > 1.5 as an indicator for intervention (Evidence: Moderate 5).
  • Post-Procedure Echocardiography: Perform immediate and follow-up echocardiograms to ensure successful closure (Evidence: Strong 1).
  • Surgical Intervention for Complex Cases: Opt for surgical closure in cases unsuitable for transcatheter methods or with complex anatomical features (Evidence: Moderate 1).
  • Regular Follow-Up: Schedule annual echocardiograms and clinical evaluations post-closure to monitor for complications (Evidence: Moderate 1).
  • Consider Comorbidities: Evaluate and manage coexisting cardiovascular conditions before intervention (Evidence: Moderate 1).
  • Minimize Hospital Stay: Transcatheter closure generally results in shorter hospital stays and lower complication rates compared to surgery (Evidence: Strong 12).
  • Monitor for Arrhythmias: Regularly screen for post-procedural arrhythmias, especially in patients with significant shunting (Evidence: Moderate 1).
  • Specialized Care for Adults: Tailor management in adults considering potential comorbidities and need for multidisciplinary care (Evidence: Expert opinion 1).
  • References

    1 O'Byrne ML, Glatz AC, Gillespie MJ. Transcatheter device closure of atrial septal defects: more to think about than just closing the hole. Current opinion in cardiology 2018. link 2 O'Byrne ML, Gillespie MJ, Shinohara RT, Dori Y, Rome JJ, Glatz AC. Cost comparison of transcatheter and operative closures of ostium secundum atrial septal defects. American heart journal 2015. link 3 Kim DH, Kang DH, Park JH, Huh KY, Jeong B, Lee W et al.. Compact programmable transmit scheme for contrast imaging using nonlinear difference-frequency ultrasound signals. Medical image analysis 2026. link 4 Wu MH, Chen HC, Wang JK, Kao FY, Huang SK. Paradigm shift in the intervention for secundum atrial septal defect in an era of transcatheter closure: A national birth cohort study. American heart journal 2015. link 5 Somura J, Nakagawa M, Ukiami M, Sagawa H, Furukawa O, Hoshino S et al.. Relationship between electrocardiographic signs and shunt volume in atrial septal defect. Pediatrics international : official journal of the Japan Pediatric Society 2015. link 6 Fan X, Hynynen K. A study of various parameters of spherically curved phased arrays for noninvasive ultrasound surgery. Physics in medicine and biology 1996. link

    Original source

    1. [1]
      Transcatheter device closure of atrial septal defects: more to think about than just closing the hole.O'Byrne ML, Glatz AC, Gillespie MJ Current opinion in cardiology (2018)
    2. [2]
      Cost comparison of transcatheter and operative closures of ostium secundum atrial septal defects.O'Byrne ML, Gillespie MJ, Shinohara RT, Dori Y, Rome JJ, Glatz AC American heart journal (2015)
    3. [3]
      Compact programmable transmit scheme for contrast imaging using nonlinear difference-frequency ultrasound signals.Kim DH, Kang DH, Park JH, Huh KY, Jeong B, Lee W et al. Medical image analysis (2026)
    4. [4]
    5. [5]
      Relationship between electrocardiographic signs and shunt volume in atrial septal defect.Somura J, Nakagawa M, Ukiami M, Sagawa H, Furukawa O, Hoshino S et al. Pediatrics international : official journal of the Japan Pediatric Society (2015)
    6. [6]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG